CAY10650 is a highly potent cytosolic phospholipase A2α (cPLA2α) inhibitor with an IC50 value of 12nM[1]. cPLA2α is a crucial enzyme involved in the hydrolysis of phospholipids to release arachidonic acid and is essential for mediating inflammatory responses and cellular signaling pathways[2][3]. CAY10650 is typically used for studying inflammation and cellular signaling pathways related to phospholipase A2[4][5].
In vitro, CAY10650 (12nM; 30min) inhibit the phosphorylation of cPLA2α, and reduced lipid body formation and PGE2 secretion in human neutrophils stimulated with Cr-LAAO[1].
In vivo, CAY10650 (50μg in 5μl eye-drop) attenuated corneal inflammation and decreased neutrophil infiltration when applied topically three times daily for 6 days and then daily from days 7 to 15 post-infection in Chinese hamsters infected with Acanthamoeba castellanii in the eyes[6]. CAY10650 (20μg/ear/day) reduced ear thickness, epidermal thickness, and inflammatory infiltrates in an IMQ-induced psoriasis mouse model when applied topically for 5 days[7].
References:
[1] Paloschi MV, Lopes JA, Boeno CN, et al. Cytosolic phospholipase A2-α participates in lipid body formation and PGE2 release in human neutrophils stimulated with an L-amino acid oxidase from Calloselasma rhodostoma venom. Sci Rep. 2020;10(1):10976.
[2] Murakami M, Kudo I. Phospholipase A2. J Biochem. 2002;131(3):285-292.
[3] Yang D, Ji HF, Zhang XM, et al. Protective effect of cytosolic phospholipase A2 inhibition against inflammation and degeneration by promoting regulatory T cells in rats with experimental autoimmune encephalomyelitis. Mediators Inflamm. 2014;2014:890139.
[4] Lin CY, Xu WB, Li BZ, Shu MA, Zhang YM. Identification and functional analysis of cytosolic phospholipase A2 (cPLA2) from the red swamp crayfish Procambarus clarkii: The first evidence of cPLA2 involved in immunity in invertebrates. Fish Shellfish Immunol. 2023;140:108944.
[5] Wu CZ, Li X, Hong L, et al. NOX4/Src regulates ANP secretion through activating ERK1/2 and Akt/GATA4 signaling in beating rat hypoxic atria. Korean J Physiol Pharmacol. 2021;25(2):159-166.
[6] Tripathi T, Abdi M, Alizadeh H. Role of phospholipase A₂ (PLA₂) inhibitors in attenuating apoptosis of the corneal epithelial cells and mitigation of Acanthamoeba keratitis. Exp Eye Res. 2013;113:182-191.
[7] Shao S, Chen J, Swindell WR, et al. Phospholipase A2 enzymes represent a shared pathogenic pathway in psoriasis and pityriasis rubra pilaris. JCI Insight. 2021;6(20):e151911.
















